Skip to main content
HONZ PHARMACEUTICAL CO., LTD. logo

HONZ PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 300086 ISIN · CNE100000QM6 LEI · 300300SA7ZULJ816T861 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,012 across all filing types
Latest filing 2021-06-29 AGM Information
Country CN China
Listing Shenzhen Stock Exchange 300086

About HONZ PHARMACEUTICAL CO., LTD.

https://www.honz.com.cn

HONZ Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical products, with a specialized emphasis on pediatric healthcare. The company provides a diverse range of medications specifically formulated for children, including antipyretics, analgesics, respiratory treatments, and anti-infective agents. It utilizes advanced drug delivery systems and taste-masking technologies to enhance patient compliance and therapeutic efficacy. In addition to its pediatric portfolio, the organization produces various chemical drugs and traditional Chinese medicine preparations. The company maintains multiple production bases and research centers dedicated to advancing clinical solutions and ensuring high standards of product quality across its therapeutic categories.

Recent filings

Filing Released Lang Actions
关于康芝药业股份有限公司2020年度股东大会的法律意见书
AGM Information Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the legality and validity of the 2020 Annual General Meeting (AGM) of 康芝药业股份有限公司. It details the procedures of the AGM, the qualifications of attendees, the agenda items discussed, and the voting results for each agenda item. The document does not contain the actual annual report or financial statements but rather confirms the proper conduct and legality of the AGM and its resolutions. It is not a full Annual Report (10-K) or an Earnings Release (ER), nor is it a Proxy Solicitation or Voting Results announcement. The document is a legal opinion related to the AGM proceedings, which fits best under the category of AGM Information (AGM-R), as it pertains to materials shared or related to the Annual General Meeting.
2021-06-29 Chinese
2020年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2020 Annual General Meeting (AGM) of 康芝药业股份有限公司. It includes information about the meeting date, attendance, voting results on various proposals including the annual report, financial statements, profit distribution plan, appointment of auditors, and other corporate matters. The document also mentions the legal opinion confirming the legality of the meeting and resolutions. The content is focused on the AGM proceedings and voting outcomes rather than the full annual report or financial statements themselves. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (5399 characters) and detailed voting results support this classification with high confidence.
2021-06-29 Chinese
关于实际控制人股份减持计划时间届满的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the expiration of a share reduction plan by the actual controller of the company. It details that the planned share reduction period has ended without any shares being sold. The document references regulatory rules about share reduction by shareholders and senior management but does not contain financial statements or detailed financial data. It is a formal disclosure about shareholding changes and compliance with regulations, specifically about a shareholding reduction plan's expiration and status. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes or plans related to significant share ownership levels. The document length is short and focused on this specific shareholder activity, not a full report or financial release.
2021-06-21 Chinese
关于公司出售广东康芝医院管理有限公司100%股份的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the sale of 100% equity in Guangdong Kangzhi Hospital Management Co., Ltd. by Kangzhi Pharmaceutical Co., Ltd. It includes transaction overview, parties involved, financial data, transaction terms, payment conditions, and strategic cooperation details. The document is lengthy (over 11,000 characters) and contains substantive financial data and analysis related to the transaction. It is not a full annual or interim report, nor is it a simple announcement of a report publication. It is a capital/financing update related to a significant equity sale and strategic partnership. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2021-06-18 Chinese
独立董事关于第五届董事会第十六次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on matters discussed at the company's fifth board of directors' sixteenth meeting, including approval of a transaction and guarantee provision. It references compliance with company law and internal regulations, and it is a formal opinion rather than a full report or announcement of voting results. The document length is short (886 characters), and it does not contain financial statements or detailed financial data. It is not a report publication announcement or a certification letter. The content fits best with Board/Management Information (MANG), as it relates to board meeting matters and independent directors' opinions on corporate actions.
2021-06-18 Chinese
关于召开2020年度股东大会补充通知的公告（增加临时提案后）
AGM Information Classification · 95% confidence The document is a detailed announcement regarding the convening of the 2020 Annual General Meeting (AGM) of 康芝药业股份有限公司, including the date, agenda items, voting procedures, and proxy forms. It includes information about the meeting logistics, proposals to be voted on, and instructions for shareholders to participate either in person or via internet voting. The document does not contain financial statements or detailed financial analysis but serves as a formal notice and supplementary information for the AGM. Therefore, it fits the category of AGM Information (AGM-R). The document length (6475 characters) and content confirm it is not a brief announcement or a report publication notice but a full AGM notice with detailed materials.
2021-06-18 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.